Why determine only the total prostate-specific antigen, if the free-to-total ratio contains the information?

Ann Clin Biochem 2008;45:270-274
doi:10.1258/acb.2007.007014
© 2008 Association for Clinical Biochemistry

 

This Article

Figures Only

Full Text

Full Text (PDF)


Alert me when this article is cited

Alert me if a correction is posted
Services

Email this article to a friend

Similar articles in this journal


Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles
Citing Articles via Google Scholar
Google Scholar

Articles by Eekers, D. B. P.

Articles by ten Kate, J.
Search for Related Content
PubMed

PubMed Citation
Social Bookmarking

What’s this?

Original Articles


Daniëlle Berty Petra Eekers1,
Andrea Laschet2,
Monique de Groot3,
Erik Roelofs4,
Arnold Kester5,
Karl Delaere6,
Philippe Lambin4,
Francis van Gils4,
Marius Nap7 and
Joop ten Kate8


1 Dr Bernard Verbeeten Institute, Tilburg, The Netherlands;
2 Department of Clinical Chemistry, Atrium Medical Centre, Heerlen, The Netherlands;
3 Department of Clinical Chemistry, Amphia Hospital, Breda, The Netherlands;
4 Maastricht Radiation Oncology, Maastricht, The Netherlands;
5 Department of Methodology and Statistics, Maastricht University, Maastricht, The Netherlands;
6 Department of Urology;
7 Department of Pathology, Atrium Medical Centre, Heerlen, The Netherlands;
8 Department of Clinical Chemistry, Maasland Hospital, Sittard, The Netherlands


Corresponding author: Dr Daniëlle Berty Petra Eekers. Email: eekers.d{at}bvi.nl


Background: Total prostate-specific antigen (tPSA) is the best availabletest for the detection of prostate cancer but it lacks specificity.The free-to-total ratio (F/T ratio) is used to increase specificityin the range of tPSA of 4–10 µg/L.

Materials and methods: Four hundred and seven biopsy results and quantitative tPSAand F/T ratio data were combined. Using the histological determination,normal/hyperplasia versus malignant as a gold standard, receiveroperating characteristic (ROC) curves as well as the areas underthe curve (AUC) for tPSA and F/T ratio were determined. Thedifferences between the two AUCs were considered for varioustPSA ranges and specificities of F/T ratio and tPSA were calculated.

Results: In the total group, there was a gain of specificity of 11% (from23% to 34%) when the sensitivity was 92% (using a cut-off >0.28for the F/T ratio and a cut-off >4 µg/L for tPSA).When considering the group of patients for which the F/T ratiois currently used (4–10 µg/L), the gain of specificitywas 27% (from 2% to 29%). This implicates that the number ofunnecessary biopsies taken will be reduced by 27%. Moreover,the AUC of the F/T ratio was significantly higher at an evenbroader range of tPSA, i.e. up to 40 µg/L.

Conclusions: This study demonstrates that the F/T ratio has better diagnosticperformance than tPSA, not only in the grey zone of tPSA, butalso outside the grey zone, i.e. up to 40 µg/L.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What’s this?